Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma, T-Cell, Peripheral 7Ovarian Neoplasms 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma 6Leukemia, Myeloid, Acute 6Lymphoma, T-Cell, Cutaneous 5Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 5Recurrence 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Lung Neoplasms 4Hodgkin Disease 4Hematologic Neoplasms 4Waldenstrom Macroglobulinemia 3Urinary Bladder Neoplasms 3Sarcoma 3Neoplasms 3Myelodysplastic Syndromes 3Mycosis Fungoides 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Immunoblastic Lymphadenopathy 3Fallopian Tube Neoplasms 3Burkitt Lymphoma 3Thyroid Neoplasms 2

Interventions

Ifosfamide 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Cisplatin 2pembrolizumab 1belinostat 1Vindesine 1Vincristine 1Topotecan 1Thoracoscopy 1Sucralfate 1Salts 1Robotic Surgical Procedures 1Rituximab 1Radiation 1Prednisolone 1Peripheral Blood Stem Cell Transplantation 1Mitozytrex 1Mitomycin 1Methotrexate 1Iodized Oil 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Ethiodized Oil 1Docetaxel 1Diffusion Tensor Imaging 1Dexamethasone 1Cytarabine 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mediastinal Neoplasms × belinostat × Clear all
NCT00589290 2015-09-30

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
41 enrolled 8 charts
Thoracic

Mediastinal Neoplasms, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡